跳至主要内容
临床试验/EUCTR2014-000669-39-DK
EUCTR2014-000669-39-DK进行中(未招募)1 期

Endoscopic treatment of neoplasia in the upper urinary tract and the value of fluorescence guided endoscopic follow up.

Gregers Gautier Hermann0 个研究点目标入组 20 人开始时间: 2014年4月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Low grade (WHO grade 1 or 2) tumours in the upper urinary tract.
  • -Patients with urothelial tumours and where RNU (radical nephroureterectomy) cannot be performed (due to one kidney, horseshoe shaped kidney, bilateral disease or co-morbidity which makes bigger surgery impossible)
  • -Tumour limited to renal pelvis and one calyx or limited to two calyxes
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • -Patients with porphyria
  • -Macroscopic haematuria, as it might interfere with the fluorescence guided cysto-ureteroscopy
  • -Known hypersensitivity to 5-ALA or porphyrins
  • -Pregnant or breast-feeding women (women of childbearing age will have a pregnancy test)
  • -Expected poor study compliance
  • -Patients < 18 years
  • -Patients who do not read or understand Danish

研究者

发起方
Gregers Gautier Hermann

相似试验